Glucose monitoring and patient safety

Point of Care

Volumn 7, Issue 4, 2008, Pages 253-257

  Price, Christopher P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Blood glucose; Diabetes mellitus; Health outcomes; Intensive care; Point of care testing; Self monitoring

Indexed keywords

EID: 67650112029     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e318188bb1c     Document Type: Article

References (45)

1. Institute of Medicine, Committee on Quality of Health Care in America. To Err is Human; Building a Safer Health System. Washington DC: National Academy Press; 2001:287.
2. Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm; a New Health System for the 21st Century. Washington, DC: National Academy Press; 2001:337.
3. Lord Darzi. NHS Next Stage Review Interim Report. Our NHS, Our Future. Department of Health, London, 2007. Available at: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/ Publications PolicyAndGuidance/DH- 079078. Accessed June 2, 2008.
4. In: Glasziou P, Irwig L, Aronson JK, eds. Evidence-based Medical Monitoring. London: Blackwell Publishing; 2008:376.
5. Godslang IF. Intra-individual variation: significant changes in parameters of lipid and carbohydrate metabolism in the individual and intra-individual variation in different test populations. Ann Clin Biochem. 1985;22:618-624.
6. Harris EK, Kanofsky P, Shakarji G, et al. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. Clin Chem. 1970;16:1022-1027.
7. Eckfeldt J, Chambless LI, Shen Y. Short-term, within-person variability in clinician chemistry test results. Arch Pathol Lab Med. 1994;118: 496-500.
8. Ricos C, Alvarez V, Cava F, et al. Desirable specifications for total error, imprecision, and bias derived from biologic variation. Available at: http://www.westgard.com/biodatabase1.htm. Accessed June 2, 2008.
9. Fraser CG, Petersen PH. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem. 1999;45:321-323.
10. Boyd JC, Brims DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47:209-214.
11. Skeie S, Thue G, Nerhus K, et al. Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem. 2002;48:994-1003.
12. Raine CH. Self-monitored blood glucose: a common pitfall. Endocr Pract. 2003;9:137-139.
13. Kristensen GB, Nerhus K, Thue G, et al. Standardized evaluation of instruments for self-monitoring of blood glucose by patients and a technologist. Clin Chem. 2004;50:1068-1071.
14. Baum JM, Monhaut NM, Parker DR, et al. Improving the quality of self-monitoring blood glucose measurement: a study in reducing calibration errors. Diabetes Technol Ther. 2006;8:347-357.
15. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31:S12-S54.
16. National Institute for Health and Clinical Excellence. Type 1 diabetes in adults; full guideline. Available at: http://www.nice.org.uk/guidance/ index.jsp?action=download&o=29396. Accessed June 2, 2008.
17. National Institute for Health and Clinical Excellence. Type 2 diabetes; the management of type 2 diabetes (update). Available at: http://www.nice.org. uk/guidance/index.jsp?action=byID&o=11983. Accessed June 2, 2008.
18. International Diabetes Federation. Global guideline for type 2 diabetes. Available at: http://www.idf.org/home/index.cfm?node=1457. Accessed June 2, 2008.
19. Coster S, Gulliford MC, Seed PT, et al. Monitoring blood glucose control in diabetes mellitus: a systematic review. Health Technol Assess. 2000;4:1-93.
20. Sarol JN, Nicodemus NA, Tan KM, et al. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin. 2005;21:173-184.
21. Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28:1510-1517.
22. Jansen JP. Self-monitoring of glucose on type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin. 2006;22:671-681.
23. McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev. 2007; 23:423-440.
24. Bossuyt PM, Lijmer JG, Mol BW. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet. 2000; 356:1844-1847.
25. Piette JD, Glasgow RE. Education and home glucose monitoring. In: Gerstein GC, Haynes RB, eds. Evidence-based Diabetes Care. Hamilton: BC Decker Inc; B;2001:207-251.
26. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes Registry. Am J Med. 2001;111:1 -9.
27. Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29:1757-1763.
28. Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA. 1996;276:1409-1415.
29. Gray A, Raikou R, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trail (UKPDS 41). BMJ. 2000;320:1373-1378.
30. Wagner EH, Sandhu N, Newton KM, et al. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001; 285:182-189.
31. Meijering S, Corstjens AM, Tulleken JE, et al. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review ofthe literature. Crit Care Med. 2006;10:R19.
32. Van den Berghe G. Insulin therapy in the intensive care unit should be targetedto maintainblood glucose between4.4 mmol/land 6.1 mmol/l. Diabetologia. 2008;51:911-915.
33. Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33: 2778-2785.
34. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345: 1359-1367.
35. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
36. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control: what is the evidence? Crit Care Med. 2007;35(9 suppl): S496-S502.
37. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151-3159.
38. Schetz M, Vanhorebeek I, Wouters PJ, et al. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol. 2008;19:571-578.
39. Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64:1348-1353.
40. Shaw GM, Chase JG, Wong J, et al. Rethinking glycaemic control in critical illness-from concept to clinical practice change. Crit Care Resusc. 2006;8:90-99.
41. Van den Berghe G, Wouters PJ, Kesteloot K, et al. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34:612-616.
42. Noel HC, Vogel DC, Erdos JJ, et al. Home telehealth reduces healthcare costs. Telemed JE Health. 2004;10:170-183.
43. Cherry JC, Moffatt TP, Rodriguez C, et al. Diabetes disease management program for an indigent population empowered by telemedicine technology. Diabetes Technol Ther. 2002;4:783-791.
44. Farmer A, Gibson OJ, Tarassenko L, et al. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet Med. 2005;22:1372-1378.
45. Farmer AJ, Gibson OJ, Dudley C, et al. A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with type 1 diabetes (ISRCTN 46889446). Diabetes Care. 2005;28:2697-2702.